tiprankstipranks
Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA
Holding ENTA?
Track your performance easily

Enanta Pharmaceuticals (ENTA) Financial Statements

163 Followers

Enanta Pharmaceuticals Financial Overview

Enanta Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.486; its P/E ratio is -1.14; Enanta Pharmaceuticals is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $-1.27. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue$ 14.61M$ 17.97M$ 18.00M$ 18.89M$ 17.80M
Gross Profit$ 14.61M$ 17.97M$ 18.00M$ 18.89M$ 17.80M
EBIT$ -29.19M$ -20.70M$ -30.59M$ -32.85M$ -37.61M
EBITDA$ -28.71M$ -20.40M$ -29.95M$ -30.85M$ -37.07M
Net Income Common Stockholders$ -28.82M$ -22.66M$ -33.41M$ -39.06M$ -37.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 248.19M$ 230.09M$ 337.15M$ 386.58M$ 210.08M
Total Assets$ 376.65M$ 398.82M$ 428.50M$ 495.17M$ 326.44M
Total Debt$ 55.47M$ 50.57M$ 25.49M$ 27.70M$ 28.00M
Net Debt$ -192.72M$ -179.52M$ -311.66M$ -358.88M$ -182.09M
Total Liabilities$ 247.84M$ 248.48M$ 236.62M$ 257.35M$ 55.65M
Stockholders Equity$ 128.81M$ 150.34M$ 191.88M$ 237.82M$ 270.80M
Cash Flow-
Free Cash Flow$ -19.35M$ -21.32M$ -25.77M$ -34.28M$ -16.17M
Operating Cash Flow$ -10.40M$ -14.78M$ -24.99M$ -32.13M$ -13.78M
Investing Cash Flow$ 19.07M$ -6.34M$ -13.12M$ -145.75M$ 46.77M
Financing Cash Flow$ -7.21M$ -6.65M$ -7.35M$ 199.88M$ -2.03M
Currency in USD

Enanta Pharmaceuticals Earnings and Revenue History

Enanta Pharmaceuticals Debt to Assets

Enanta Pharmaceuticals Cash Flow

Enanta Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis